Tumor marker CA 11-19 as a new serum blood test for monitoring colorectal cancer.

医学 结直肠癌 内科学 胃肠病学 粪便潜血 癌症 癌胚抗原 肿瘤标志物 阶段(地层学) 抗原 血液检验 肿瘤科 结肠镜检查 免疫学 生物 古生物学
作者
John J. Costanzi,T. Jordan,Lisa Jensen-long
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:34 (4_suppl): 536-536
标识
DOI:10.1200/jco.2016.34.4_suppl.536
摘要

536 Background: Colorectal cancer remains the third most frequent cause of cancer deaths globally. The FOBT (fecal occult blood test) and FIT (fecal immunochemical test) as well as CEA are increasingly being used to screen or monitor patients at increased risk for colorectal cancer (CRC), however none has optimal performance in terms of both sensitivity and specificity. Data was recently published* on the new serum blood test colorectal tumor marker CA11-19. This data showed a sensitivity of 98% (95% CI, 93.1%-99.5%) and specificity of 84% (95% CI, 80.0%-87.9%) at a cut-off value of 6.5 U/mL with a high sensitivity for detection of early stage CRC as opposed to CEA whose values are reported ~40% and ~30–80%** respectively for sensitivity and specificity. This study will look at case studies that show an array of long-term monitoring outcomes which suggest possible use of CA 11-19 instead of CEA. Methods: Using a sandwich ELISA assay, a new colon cancer antigen, CA 11-19, (100 kDa glycoprotein) was measured in samples of 7 patients with a variety of conditions in normal, benign GI diseases, polyps and colon cancer. This long-term follow up is recorded from 8 to 20 years. Results: Serum samples previously frozen were used to measure the CA11-19 antigen. An average follow up time of 15 years (range 8 to 20 years) was recorded. Elevated levels of CA11-19 were detected in patients with polyps and CRC prior to treatment and decreased levels were measured after the removal of the polyps or cancer. Importantly, rising rates of CA11-19 were seen in patients with cancer recurrences of colorectal cancers. Conclusions: CA 11-19 is a serologic tumor marker for colorectal cancer with a published sensitivity of 97.7% and a specificity of 84.4%*. Preliminary reports from 7 cases show long-term data which could be more helpful in monitoring and or follow-up of high risk patients for CRC than the current CEA testing method. Additional studies are needed to further validate the use of CA 11-19 in these patient groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
NexusExplorer应助俏皮的白柏采纳,获得10
1秒前
1秒前
科目三应助药毛儿采纳,获得10
3秒前
egg发布了新的文献求助10
3秒前
lyting完成签到,获得积分10
3秒前
阿萨德完成签到,获得积分10
3秒前
万能图书馆应助多多采纳,获得10
4秒前
风起完成签到 ,获得积分10
4秒前
wwwwww完成签到,获得积分10
4秒前
量子星尘发布了新的文献求助10
5秒前
无花果应助好好采纳,获得10
5秒前
5秒前
xyx945应助创新采纳,获得10
7秒前
8秒前
9秒前
情怀应助madefu采纳,获得10
10秒前
whatever应助arrebol采纳,获得10
11秒前
秦羽发布了新的文献求助10
11秒前
专注的乐荷完成签到,获得积分20
11秒前
超级飞侠应助YYYZZX1采纳,获得10
12秒前
13秒前
14秒前
Yanz完成签到,获得积分10
15秒前
15秒前
16秒前
善良的非笑完成签到,获得积分10
18秒前
18秒前
小二郎应助jiabaoyu采纳,获得10
18秒前
无奈秋荷发布了新的文献求助10
19秒前
20秒前
黄哈哈发布了新的文献求助10
21秒前
多多发布了新的文献求助10
21秒前
23秒前
李健的小迷弟应助Brian采纳,获得10
23秒前
23秒前
23秒前
liujian完成签到,获得积分10
24秒前
24秒前
脑洞疼应助wl301采纳,获得20
25秒前
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988827
求助须知:如何正确求助?哪些是违规求助? 3531197
关于积分的说明 11252739
捐赠科研通 3269830
什么是DOI,文献DOI怎么找? 1804815
邀请新用户注册赠送积分活动 881915
科研通“疑难数据库(出版商)”最低求助积分说明 809028